Episode Details
Back to Episodes
Shalin Shah - CEO of Marius Pharmaceuticals on the oral TRT partnership with Hims
Published 8 months ago
Description
Shalin Shah is the founder & CEO of Marius Pharmaceuticals, the company that partnered with $HIMS to launch oral testosterone (KYZATREX). We discuss how the partnership came about, the benefits of teaming up with $HIMS, and the future of TRT.
(00:41) Origin of the partnership
(02:55) Benefits of partnering with $HIMS
(04:14) Deal shape and exclusivity
(06:51) How KYZATREX will sit alongside compounded meds on the $HIMS platform
(09:22) Will KYZATREX be personalized?
(16:07) TRT as a schedule 3 substance
(21:39) Gearing up for 2026 launch of KYZATREX
(22:40) Future of TRT market
(27:29) Peptides
(29:44) Testosterone for females
Get full access to Hims House at himshouse.substack.com/subscribe